You are here

Allergan

Doctors expect enthusiasm for Allergan's high-flying Zeltiq to fade: survey

Fierce Pharma

Wed, 03/28/18 - 09:34 am

Racing Allergan, Biohaven Touts Migraine Drug Data, But Shares Sink

Xconomy

Mon, 03/26/18 - 09:54 am

Biohaven Pharmaceuticals

Amgen and Allergan Hopeful that Herceptin Biosimilar Approval Will Be Around the Corner

Xtalks

Mon, 03/26/18 - 09:36 am

Allergan - Forest gender discrimination $4 million settlement final date approaching

CP Wire

Thu, 03/22/18 - 03:51 pm

gender discrimination

Class Action Lawsuit

Allergan - Forest gender discrimination $4 million settlement final date approaching

Thu, 03/22/18 - 03:50 pm

gender discrimination

Class Action Lawsuit

Ocugen’s Dry Eye Disease Therapy Could Compete with Allergan and Shire

Xtalks

Wed, 03/21/18 - 10:55 am

dry eye disease

Tribe looks to stop patent board’s review of Restasis IP

Drug Delivery Business News

Tue, 03/20/18 - 11:13 am

intellectual property

Forget that 'no breakup' vow. Allergan's CEO now says a strategic review is happening

Fierce Pharma

Thu, 03/15/18 - 11:22 am

Lousy year for shareholders, but Allergan CEO Brent Saunders sprints past Gorsky, Gonzalez with $32M pay package

Endpoints

Wed, 03/14/18 - 11:36 am

Richard Gonzalez

Senators heap abuse on Allergan’s attempt at an end run around patent reviews, offer bill to stop ‘sham’

Endpoints

Fri, 03/9/18 - 11:05 am

inter partes review

U.S. judge says opioid settlement roadblocks may prompt trials

Reuters

Thu, 03/8/18 - 09:45 am

Endo International

Teva Pharmaceutical

Botox Biosimilar in Development by Mylan and Revance Therapeutics

Xtalks

Mon, 03/5/18 - 11:10 am

Revance Therapeutics

Top 5 viewed boards for week ending March 3, 2018

CP Wire

Sun, 03/4/18 - 01:50 pm

FDA pushes back PDUFA date on Allergan’s uterine fibroid drug

Fierce Biotech

Thu, 03/1/18 - 10:02 am

uterine fibroids

ulipristal acetate

Pfizer, Roche and Allergan Weigh FDA Plans for Patient-Focused Drug Development Guidance

RAPS.org

Tue, 02/27/18 - 10:40 pm

drug development

Sovereign nonsense: Patent board joins the lineup of critics dissing Allergan’s ‘illusory’ IP deal with the Mohawks

Endpoints

Mon, 02/26/18 - 11:04 pm

Allergan is dealt another setback as patent board shoots down Mohawk patent deal

Stat

Sat, 02/24/18 - 10:33 pm

Top drugmakers are counting on two hot drug fields—migraine and NASH—but payers are ready to rumble

Fierce Pharma

Thu, 02/22/18 - 11:28 pm

Teva Pharmaceutical

Gilead Sciences

Intercept Pharma

AbbVie, Allergan, Roche could join Biogen, UCB in Acorda hunt: analyst

Fierce Pharma

Fri, 02/16/18 - 09:38 pm

Acorda Therapeutics

Beat you to it, Purdue. Other opioid makers already ditched promotions

Fierce Pharma

Wed, 02/14/18 - 11:35 am

Teva Pharmaceutical

Endo International

Pages